Is Fluoxetine (Prozac) safe for babies and kids?
Moderate risk for kidsInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Fluoxetine (Prozac) poses heightened risk.
What is fluoxetine (prozac)?
The IUPAC name is N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine.
Also known as: N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine, fluoxetine, Fluoxetina, Animex-On.
- IUPAC name
- N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
- CAS number
- 54910-89-3
- Molecular formula
- C17H18F3NO
- Molecular weight
- 309.33 g/mol
- SMILES
- CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
- PubChem CID
- 3386
Risk for babies
Moderate riskInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Fluoxetine (Prozac) poses heightened risk.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Elevated riskFluoxetine (Prozac) poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.
Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.
Regulatory consensus
1 regulatory bodyhas classified Fluoxetine (Prozac).
| Agency | Year | Classification | Notes |
|---|---|---|---|
| FDA | — | Black Box Warning | increased risk of suicidal thinking and behavior in children, adolescents, and young adults (≤24 years) with MDD and other psychiatric disorders during initial treatment |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter fluoxetine (prozac)
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Fluoxetine (Prozac):
-
Therapeutic alternatives (consult prescriber)
Trade-offs: Drug-specific. Cannot substitute without medical guidance.Relative cost: 1.2-2×
Frequently asked questions
Is fluoxetine (prozac) safe for kids?
Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Fluoxetine (Prozac) poses heightened risk.
What products contain fluoxetine (prozac)?
Fluoxetine (Prozac) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to fluoxetine (prozac)?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
See Fluoxetine (Prozac) in the baby app
Look up products containing fluoxetine (prozac), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (2)
- FDA Prescribing Information: Fluoxetine (Prozac) — MDD/OCD/panic/bulimia; Black Box suicidality; CYP2D6 inhibitor; serotonin syndrome; pediatric MDD ≥8yr; Reconcile veterinary approval; long half-life; overdose profile (2023) (2023) — regulatory
- ASPCA Animal Poison Control Center: SSRI/SNRI Toxicosis in Dogs and Cats — serotonin syndrome; cyproheptadine treatment; toxic dose thresholds; fluoxetine/sertraline/paroxetine/escitalopram comparison; clinical signs and management (2023) (2023) — veterinary
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →